A. Kirschenbaum

发表

Raheleh Hatami Survival KLF 6-SV 1 Drives Breast Cancer Metastasis and Is Associated with Poor

J. Foekens, A. Sieuwerts, M. Look, 2013 .

losses with androgens: quantification by MRI Reversal of weightlessness-induced musculoskeletal

K. Westlund, A. Levine, A. Kirschenbaum, 2015 .

Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.

A. Levine, A. Kirschenbaum, Xin-hua Liu, 2005, Endocrinology.

Androgen deprivation therapy as primary treatment for prostate cancer.

A. Levine, A. Kirschenbaum, Dara Cannata, 2012, The Journal of clinical endocrinology and metabolism.

Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells.

A. Levine, A. Kirschenbaum, S. Aaronson, 2007, Cancer research.

Overview of prostate anatomy, histology, and pathology.

A. Kirschenbaum, Christine H. Lee, O. Akin-Olugbade, 2011, Endocrinology and metabolism clinics of North America.

Androgens Promote Preosteoblast Differentiation via Activation of the Canonical Wnt Signaling Pathway

A. Levine, A. Kirschenbaum, Xin-hua Liu, 2007, Annals of the New York Academy of Sciences.

Immunohistochemical localization of steroid 5 alpha-reductase 2 in the human male fetal reproductive tract and adult prostate.

D. Russell, A. Levine, A. Kirschenbaum, 1996, The Journal of clinical endocrinology and metabolism.

Cyclooxygenase-2 Suppresses Hypoxia-induced Apoptosis via a Combination of Direct and Indirect Inhibition of p53 Activity in a Human Prostate Cancer Cell Line*

A. Levine, A. Kirschenbaum, Xin-hua Liu, 2005, Journal of Biological Chemistry.

Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation

A. Leiter, A. Levine, A. Kirschenbaum, 2011, Annals of the New York Academy of Sciences.

Estrogen receptor messenger RNA expression in human benign prostatic hyperplasia: detection, localization, and modulation with a long-acting gonadotropin-releasing hormone agonist.

A. Levine, A. Kirschenbaum, M. Ren, 1994, Journal of andrology.

Effect of a GnRH analogue (leuprolide) on benign prostatic hypertrophy.

A. Levine, A. Kirschenbaum, J. Gabrilove, 1987, The Journal of clinical endocrinology and metabolism.

Nandrolone, an anabolic steroid, stabilizes Numb protein through inhibition of mdm2 in C2C12 myoblasts.

A. Levine, A. Kirschenbaum, W. Bauman, 2012, Journal of andrology.

Controversies in urologic oncology.

N. Stone, A. Kirschenbaum, M. Droller, 1988, The Surgical clinics of North America.

Immunohistochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the human fetal and adult male reproductive tracts.

P. Unger, I. Leav, A. Levine, 2000, The Journal of clinical endocrinology and metabolism.

Enhanced androgen sensitivity in serum-free medium of a subline of the LNCaP human prostate cancer cell line

A. Levine, A. Kirschenbaum, M. Ren, 1993, Steroids.

Effect of long-acting gonadotropin-releasing hormone analog (leuprolide) therapy on prostatic size and symptoms in 15 men with benign prostatic hypertrophy.

A. Levine, A. Kirschenbaum, J. Gabrilove, 1989, The Journal of clinical endocrinology and metabolism.

The role of the interleukin-6/gp130 signaling pathway in bone metabolism.

A. Levine, A. Kirschenbaum, Xin-hua Liu, 2006, Vitamins and hormones.

Bone extracellular matrix induces homeobox proteins independent of androgens: Possible mechanism for androgen‐independent growth in human prostate cancer cells

A. Levine, A. Kirschenbaum, D. Miniati, 1996, The Prostate.

Serum prostate-antigen levels in patients with benign prostatic hypertrophy treated with leuprolide.

A. Levine, A. Kirschenbaum, P. Kaplan, 1989, Urology.

Androgens Upregulate Transcription of the Notch Inhibitor Numb in C 2 C 12 Myoblasts via Wnt / β-catenin Signaling to Tcf Elements in the Numb Promoter *

A. Levine, A. Kirschenbaum, W. Bauman, 2013 .

Urinary bladder adenocarcinoma arising in a spina bifida patient.

P. Unger, A. Kirschenbaum, E. Mandel, 2007, Annals of diagnostic pathology.

Prostaglandin E2 Stimulates Prostatic Intraepithelial Neoplasia Cell Growth through Activation of the Interleukin-6/GP130/STAT-3 Signaling Pathway

A. Levine, A. Kirschenbaum, A. Klausner, 2002 .

The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates.

A. Levine, A. Kirschenbaum, M. Ren, 1992, Endocrinology.

Nandrolone reduces activation of Notch signaling in denervated muscle associated with increased Numb expression.

A. Levine, A. Kirschenbaum, W. Bauman, 2011, Biochemical and biophysical research communications.

Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.

S. Izadmehr, A. Levine, A. Kirschenbaum, 2016, Endocrinology.

Management of hormonal treatment effects

A. Kirschenbaum, 1995 .

Primary renal carcinoid tumor.

P. Unger, A. Kirschenbaum, R. Schlussel, 1993, Urology.

Lack of correlation between prostate-specific antigen density and prostatic shrinkage in response to finasteride therapy

A. Levine, A. Kirschenbaum, E. Pacheco, 2004, World Journal of Urology.

Ribosome‐inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase‐1 selectively in premalignant and malignant prostate cancer cells

A. Levine, A. Kirschenbaum, A. Difeo, 2009, International journal of cancer.

Ureteroscopic management of ureteral cholesteatoma.

A. Kirschenbaum, E. L. Cohen, H. Mitty, 1986, Urology.

Preclinical evaluation of PDS (polydioxanone) synthetic absorbable suture vs chromic surgical gut in urologic surgery.

A. Kirschenbaum, J. Glenn, E. L. Cohen, 1987, Urology.

The effect of dihydrotestosterone and culture conditions on proliferation of the human prostatic cancer cell line LNCaP

A. Kirschenbaum, J. Mandeli, V. Hollander, 1992, Steroids.

Update on oncogenes and relevance in urology.

A. Kirschenbaum, M. Droller, 1987, Urology.

Metastatic Malignant Melanoma to Urinary Bladder

P. Unger, A. Kirschenbaum, A. Rishi, 2014, International journal of surgical pathology.

Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts.

P. Greenberg, A. Levine, A. Kirschenbaum, 1998, Endocrinology.

Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.

A. Levine, A. Kirschenbaum, J. Holland, 2000, The Journal of urology.

Androgens Up-regulate Transcription of the Notch Inhibitor Numb in C2C12 Myoblasts via Wnt/β-Catenin Signaling to T Cell Factor Elements in the Numb Promoter*

A. Levine, A. Kirschenbaum, W. Bauman, 2013, The Journal of Biological Chemistry.

Interactive Effect of Interleukin‐6 and Prostaglandin E2 on Osteoclastogenesis via the OPG/RANKL/RANK System

A. Levine, A. Kirschenbaum, Xin-hua Liu, 2006, Annals of the New York Academy of Sciences.

Oncogenes and genitourinary neoplasia

A. Kirschenbaum, M. Droller, 1987 .

NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.

A. Levine, A. Kirschenbaum, Xin-hua Liu, 1998, Cancer research.

Abstract 5314: An oncogenic splice variant of the KLF6 tumor suppressor gene is associated with poor survival and is a potent driver of breast cancer metastasis

J. Foekens, A. Sieuwerts, Raheleh Hatami, 2012 .

Effect of the addition of estrogen to medical castration on prostatic size, symptoms, histology and serum prostate specific antigen in 4 men with benign prostatic hypertrophy.

A. Levine, A. Kirschenbaum, J. Gabrilove, 1991, The Journal of urology.

Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.

S. Friedman, J. Martignetti, A. Levine, 2005, Cancer research.

The role of cyclooxygenase-2 in prostate cancer.

A. Levine, A. Kirschenbaum, Xin-hua Liu, 2001, Urology.

Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones.

S. Friedman, J. Martignetti, A. Levine, 2006, Carcinogenesis.

Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase

S. Izadmehr, A. Levine, A. Kirschenbaum, 2019, Journal of the Endocrine Society.

Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer.

R. Sears, W. Oh, M. Galsky, 2018, Cancer research.

Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line

A. Levine, A. Kirschenbaum, K. Claffey, 2004, Clinical & Experimental Metastasis.

Prostaglandin E2 Induces Hypoxia-inducible Factor-1α Stabilization and Nuclear Localization in a Human Prostate Cancer Cell Line*

A. Levine, A. Kirschenbaum, Min Lu, 2002, The Journal of Biological Chemistry.

Case Report: Biliary Obstruction Complicating Extracorporeal Shock Wave Lithotripsy

A. Kirschenbaum, B. Saltzman, A. Krongrad, 1988 .

KLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival

J. Foekens, A. Sieuwerts, M. Look, 2013, Science Translational Medicine.

Oncocytoma and metastatic potential: myth or reality?

M. Tannenbaum, A. Kirschenbaum, M. Droller, 1987, World Journal of Urology.

Case and Management of Incidentalomas in Patients with Von Hippel-Lindau Disease

A. Kirschenbaum, B. Chughtai, R. O'Malley, 2005, Urologia Internationalis.

Concomitant secretion of glucocorticoid, androgens, and mineralocorticoid by an adrenocortical carcinoma: case report and review of literature.

P. Unger, A. Levine, A. Kirschenbaum, 2007, Endocrine Practice.

Lack of effect of a gonadotropin-releasing hormone agonist in a patient with prostate cancer and a gonadotroph adenoma.

A. Levine, A. Kirschenbaum, K. Post, 1996, The Journal of clinical endocrinology and metabolism.

Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate.

P. Unger, A. Levine, A. Kirschenbaum, 2000, Urology.

The role of sex steroids in the pathogenesis and maintenance of benign prostatic hyperplasia.

A. Levine, A. Kirschenbaum, J. Gabrilove, 1997, The Mount Sinai journal of medicine, New York.

Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cells.

A. Levine, A. Kirschenbaum, M. Zaidi, 2010, Biochemical and biophysical research communications.

Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway.

A. Levine, A. Kirschenbaum, A. Klausner, 2002, Biochemical and biophysical research communications.

Nafarelin acetate and benign prostatic hyperplasia.

P. Walsh, A. Kirschenbaum, A. Levine, 1988, The New England journal of medicine.

MUC1 Expression in Prostate Carcinoma: Correlation with Grade and Stage.

Levine, Yao, A. Kirschenbaum, 1999, Molecular urology.

Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumors.

A. Levine, A. Kirschenbaum, S. Aaronson, 1997, Urologic oncology.

Estrogen receptor messenger RNA expression in human benign prostatic hyperplasia: detection, localization, and modulation with a long-acting gonadotropin-releasing hormone agonist.

A. Levine, A. Kirschenbaum, B. Schachter, 1994, Journal of andrology.